gtag('event', 'click', { 'event_category': 'PDF Download' });
was successfully added to your cart.

Cart

CLDF NewsResearch News Updates and Blogs

DR JAKE MANN: IDENTIFICATION OF BIOMARKERS IN PAEDIATRIC FATTY LIVER DISEASE – UPDATES AND POSTER

Dr Jake Mann: Identification of biomarkers in paediatric fatty liver disease (Measuring blood fats for a ‘liquid biopsy’ in fatty liver disease)

Non-Alcoholic Fatty Liver Disease (NAFLD) is the most common liver condition affecting children. Currently the only method to reliably decide on patient management is by liver biopsy to determine fibrosis stage. At the moment, it is impossible to tell how severe the liver damage is without doing a liver biopsy, which is risky, expensive, and requires a general anaesthetic. This research seeks to identify methods for non-invasively assessing paediatric NAFLD.

Please download the PDF: NAFLD research and findings PDF  poster, kindly provided by Dr Jake Mann, which explains the research and findings so far

Join the discussion One Comment

  • Terrie Gray says:

    Fantastic news……will this ‘liquid biopsy’ be able to determine fibrosis levels in children with auto immune hepatitis and indeed, any liver disease where some degree of fibrosis is suspected ? Keep up the excellent work .

Leave a Reply

© 2019 Children's Liver Disease Foundation. All Rights Reserved.